Loading
Latest filing published 29 Mar 2024 for NervGen Pharma Corp..
No signal scores available.
Michael Kelly discloses dealings in NervGen Pharma Corp. to SEDI. We count 2 filings; the first trade dates from 10 April 2023 and the latest from 28 March 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 29 March 2024 came the latest disclosure, a transaction in NervGen Pharma Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations